Approval · Notice of Compliance 27770 · 2022
BUDESONIDE: Notice of Compliance 27770
Issued March 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27770
- Date
- March 15, 2022
- Company
- Tillotts Pharma GmbhRheinfelden, Baden-Wuerttemberg, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Labelling Update (to Match Licensor)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUDESONIDE | Not yet assigned | — |
Medicinal ingredients
- BUDESONIDE 3 MG per CAP